New Zealand markets closed

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
25.15+0.49 (+1.99%)
At close: 04:00PM EDT
25.15 0.00 (0.00%)
After hours: 05:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
35,198
60,000
26,581
27,357
28,628
Operating expenses
Research development
134,704
120,161
126,215
126,006
74,506
Selling general and administrative
32,367
33,491
31,739
27,196
18,638
Total operating expenses
167,071
153,652
157,954
153,202
93,144
Operating income or loss
-131,873
-93,652
-131,373
-125,845
-64,516
Interest expense
-
-
0
0
598
Total other income/expenses net
-164
-201
-80
-149
-631
Income before tax
-130,106
-78,955
-127,393
-125,551
-64,845
Income tax expense
-
-
0
0
1,305
Income from continuing operations
-130,106
-78,955
-127,393
-125,551
-66,150
Net income
-130,106
-78,955
-127,393
-125,551
-66,150
Net income available to common shareholders
-130,106
-78,955
-127,393
-125,551
-66,150
Basic EPS
-2.71
-1.39
-2.60
-2.71
-1.92
Diluted EPS
-2.71
-1.39
-2.60
-2.71
-1.92
Basic average shares
46,323
56,764
49,042
46,323
34,396
Diluted average shares
46,323
56,764
49,042
46,323
34,396